Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

SPX Completes Acquisition of Anhydro

By Pharmaceutical Processing | July 21, 2010

SPX Corporation today announced that it has completed the acquisition of the Anhydro business, a Soeborg, Denmark-based global supplier of liquid concentration equipment, powder processing solutions, and dewatering plants and equipment. The terms of the transaction were not disclosed.

Anhydro supplies a wide range of evaporation and drying solutions for dairy, food, and starch producers and for the chemical and pharmaceutical industries worldwide. The transaction includes all Anhydro’s business units with the exception of its Danish Filter business, Simatek A/S, and its German, U.K. and U.S. operations, as well as certain individual projects. The acquired business units employ 225 employees and are expected to generate 2010 full-year revenue of approximately 85 million Euros.

“The addition of Anhydro broadens our technology equipment offerings and systems capabilities and strengthens our ability to serve customers in the global food, pharmaceutical and chemical processing end markets,” said SPX Chairman, President and Chief Executive Officer Christopher J. Kearney. “This strategic transaction also builds on our recent acquisition of Gerstenberg Schroder and underscores our commitment to expanding our Flow Technology segment, which remains a key component of our global growth strategy.” SPX first announced that it had entered into a definitive agreement to acquire Anhydro on June 18, 2010. Anhydro will operate within SPX’s Flow Technology segment.

 

 

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE